ELL Antikörper
Kurzübersicht für ELL Antikörper (ABIN498288)
Target
Alle ELL Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Spezifität
- This antibody detects endogenous levels of ELL protein. (region surrounding Asp125)
-
Kreuzreaktivität (Details)
-
Species reactivity (expected):Mouse.
Species reactivity (tested):Human. -
Aufreinigung
- Affinity chromatography
-
Reinheit
- > 95 % by SDS-PAGE
-
-
-
-
Applikationshinweise
-
Western Blot: 1/500 - 1/1000. Immunohistochemistry: 1/50 - 1/200.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1,0 mg/mL
-
Buffer
- Phosphate buffered saline (PBS) with0.05 % sodium azide, approx. pH 7.2.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- ELL (Elongation Factor RNA Polymerase II (ELL))
-
Andere Bezeichnung
- ELL
-
Hintergrund
- ELL was shown to encode an elongation factor that can increase the catalytic rate of RNA polymerase II transcription by suppressing transient pausing by the polymerase at multiple sites along the DNA. ELL is the second elongation factor to be implicated in oncogenesis.Synonyms: C19orf17, Eleven-nineteen lysine-rich leukemia protein, RNA polymerase II elongation factor ELL
-
Molekulargewicht
- approx. 65 kDa
-
Gen-ID
- 8178
-
NCBI Accession
- NP_006523
-
UniProt
- P55199
Target
-